🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
Allogeneic (Allo) hematopoietic stem cell transplantation (HSCT) is a recog...
Status
Completed
Location
CHU Amiens
Start Date
2016-02-23
Trial ID
NCT02623309
Treatments Being Tested
To assess the engraftment of hematopoietic stem cells following reduced-int...
Status
Unknown
Location
Paillard Catherine
Start Date
2007-04
Trial ID
NCT00750126
Treatments Being Tested
DSHNHL R3 is a randomized clinical phase II study. The main objective is to...
Status
Completed
Location
Universitätsklinikum Heidelberg
Start Date
2004-04
Trial ID
NCT00785330
Treatments Being Tested
Refractory/Relapsed (R/R) acute myeloid leukemia (AML) is associated with a...
Status
Recruiting
Location
CHU de Lille
Start Date
2025-07-10
Trial ID
NCT06649227
Treatments Being Tested
Usually Chronic lymphocytic leukemia (CLL) is a disease of the elderly pati...
Status
Unknown
Location
CHU Clermont-Ferrand
Start Date
2012-09
Trial ID
NCT01849939
The purpose of this study is to evaluate the safety and efficiency of perso...
Status
Unknown
Location
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Start Date
2019-10-15
Trial ID
NCT04000698
Treatments Being Tested
The purpose of this study is to evaluate progression free survival, transpl...
Status
Unknown
Location
Città della Salute e della Scienza di Torino
Start Date
2013-02
Trial ID
NCT01786018
A Phase I/II Dose Escalation, Safety and Efficacy Study of HBI 0201-ESO TCR...
Status
Recruiting
Location
Hadassah Medical Organization
Start Date
2022-04-01
Trial ID
NCT05296564
Treatments Being Tested